These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
510 related items for PubMed ID: 19522648
1. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ. J Infect Dis; 2009 Jul 15; 200(2):263-72. PubMed ID: 19522648 [Abstract] [Full Text] [Related]
2. Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Billips BK, Schaeffer AJ, Klumpp DJ. Infect Immun; 2008 Sep 15; 76(9):3891-900. PubMed ID: 18559433 [Abstract] [Full Text] [Related]
7. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Bokil NJ, Totsika M, Carey AJ, Stacey KJ, Hancock V, Saunders BM, Ravasi T, Ulett GC, Schembri MA, Sweet MJ. Immunobiology; 2011 Nov 15; 216(11):1164-71. PubMed ID: 21802164 [Abstract] [Full Text] [Related]
8. Interaction of uropathogenic Escherichia coli with host uroepithelium. Kau AL, Hunstad DA, Hultgren SJ. Curr Opin Microbiol; 2005 Feb 15; 8(1):54-9. PubMed ID: 15694857 [Abstract] [Full Text] [Related]
10. A toll-like receptor that prevents infection by uropathogenic bacteria. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. Science; 2004 Mar 05; 303(5663):1522-6. PubMed ID: 15001781 [Abstract] [Full Text] [Related]
11. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice. Layton GT, Smithyman AM. Clin Exp Immunol; 1983 Nov 05; 54(2):305-12. PubMed ID: 6360434 [Abstract] [Full Text] [Related]
12. FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections. Nesta B, Spraggon G, Alteri C, Moriel DG, Rosini R, Veggi D, Smith S, Bertoldi I, Pastorello I, Ferlenghi I, Fontana MR, Frankel G, Mobley HL, Rappuoli R, Pizza M, Serino L, Soriani M. mBio; 2012 Nov 05; 3(2):. PubMed ID: 22496310 [Abstract] [Full Text] [Related]
13. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection. Habibi M, Asadi Karam MR, Bouzari S. Microb Pathog; 2017 Sep 05; 110():477-483. PubMed ID: 28754265 [Abstract] [Full Text] [Related]
17. Blocking adherence of uropathogenic Escherichia coli isolate to HEP-2 cells and bladder of mice in the presence of antibody against p-fimbriae. Bidhendi SM, Sattari M, Pourbakhsh SA, Mobarez A, Vandyousefi J, Khaki P, Heidari MH, Kazemnejad A. Biologicals; 2007 Apr 05; 35(2):99-105. PubMed ID: 16879977 [Abstract] [Full Text] [Related]